Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer Announces Strategic Alliance with Integromics

Published: Tuesday, June 25, 2013
Last Updated: Tuesday, June 25, 2013
Bookmark and Share
PerkinElmer becomes the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire.

OmicsOffice® 5 improves and accelerates genomic analysis workflows by enabling integrated comparison of data from microarray, next generation sequencing and qPCR experiments within the TIBCO Spotfire® analytics platform.

PerkinElmer, Inc. announced a strategic alliance with Integromics, S.L. to become the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire data visualization platform. In addition, PerkinElmer and Integromics announced the release of OmicsOffice 5.0, developed by Integromics. The new OmicsOffice software will be exclusively available from PerkinElmer under the agreement.

OmicsOffice allows users of TIBCO Spotfire to handle, process, analyze and properly visualize diverse genomics data. The software provides scientists with a rich and flexible set of statistical and functional analysis tools specifically for the study and cross-validation of microarray, next generation sequencing and qPCR data on a single platform, and allows them to extract relevant and reliable biological conclusions from genomic data. Using OmicsOffice, genomics scientists can significantly improve the quality of their results, as they respond to scalability and integration challenges in this rapidly evolving field.

Michael Stapleton, general manager, PerkinElmer Informatics said, “We are delighted that PerkinElmer will take on distribution of the new OmicsOffice product. It represents a true synergy with our mission to offer end-to-end informatics solutions throughout the research, discovery and manufacturing processes. As the exclusive worldwide distributor of OmicsOffice, we can provide focused solutions to the genomics and next generation sequencing community to improve the quality of their work and gain critical insights faster than before.”

“PerkinElmer is the perfect partner for Integromics, particularly for OmicsOffice,” said Víctor Canivell, PhD, Chief Executive Officer of Integromics. “PerkinElmer’s leadership in technologies for scientific discovery and its commitment to advanced analysis tools, provides us with an excellent opportunity to bring the power of OmicsOffice to genomic researchers, as well as to accelerate the release of new omics analysis tools.”

PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Good Start Genetics, PerkinElmer Collaboration Expands Access to Genetic Carrier Screening Tests
Strategic agreement will broaden access to GoodStart Select™ tests to include obstetrics and gynecology and maternal fetal medicine physicians.
Monday, March 17, 2014
PerkinElmer to Host Revolutionaries for Global Health Summit
Company to assemble thought leaders to share pioneering personalized health research and innovations.
Wednesday, May 01, 2013
PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Companies team up to enable large-scale sequencing studies through more efficient automation and improving next generation sequencing sample access.
Tuesday, February 21, 2012
Scientific News
How Did The Giraffe Get Its Long Neck?
Clues about the evolution of the giraffe’s long neck have now been revealed by new genome sequencing.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Collaborative Study of WES Offers New Hope
Company has announced that the collaborative study of whole exome sequencing offers new hope for children with white matter disorders.
Using Portable Nanopore DNA Sequencers to Combat Wildlife Crime
University of Leicester researchers aim to develop a test using DNA to identify species at crime scenes in as little as an hour.
TGAC Installs Largest SGI UV 300 Supercomputer for Life Sciences
The Genome Analysis Centre (TGAC) partners with Global HPC hardware giant SGI to address the most complex problems in genomics analysis.
Shining A Light On Bladder Cancer
Researchers scrutinize patterns of mutations in bladder tumor genomes, gleaning insights into the roles of DNA repair and tobacco-related DNA damage.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
New Neurodevelopmental Syndrome Identified
Study pinpoints underlying genetic mutations, raising hopes for targeted therapies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!